Table 3. Survival and status at last follow-up for the PPCM and HHFP patients studied.
PPCM (N = 30) | HHFP (N = 53) | P-value | |
---|---|---|---|
Median duration of follow-up | 3.5 years | 6 years | 0.02 |
Death | 5 (16.7) | 0 (0) | 0.005 |
Chronic heart failure | 24 (80.0) | 8 (15.1) | <0.001 |
Cardiac resynchronization therapy | 1 (3.3) | 0 (0) | 0.361 |
Intracardiac thrombus | 5 (16.7) | 0 (0) | 0.014 |
Stroke | 2 (6.7) | 0 (0) | 0.128 |
Pulmonary hypertension | 4 (13.3) | 1 (1.9) | 0.022 |
Heart transplantation | 1 (3.3) | 0 (0) | 0.361 |
NYHA FC at last visit: | <0.001 | ||
Class I and II | 18 (72.0) | 52 (98.1) | |
Class III and IV | 7 (28.0) | 1 (1.9) |
NYHA FC, New York Heart Association Functional Class.